腎上腺能受體激動劑-山東大學藥理學英文課件_第1頁
腎上腺能受體激動劑-山東大學藥理學英文課件_第2頁
腎上腺能受體激動劑-山東大學藥理學英文課件_第3頁
腎上腺能受體激動劑-山東大學藥理學英文課件_第4頁
腎上腺能受體激動劑-山東大學藥理學英文課件_第5頁
已閱讀5頁,還剩50頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)

文檔簡介

Chapter8Adrenoceptoragonists

(adrenomimeticdrugs,Sympathomimeticamines)α,β-Ragonistsα-Ragonists,β-Ragonists

Section1Structure-activityrelationshipandclassification

Chemistry

structure-activityrelationship(1)Catecholamine

(CA,兒茶酚胺)(2)

-C:blockMAO

(3)N-:

or

selective

classificationsα,β-Ragonists:

AD,ephedrine(麻黃堿)α-Ragonists

α1、α2-Ragonists

:NA

α1-Ragonists:phenylephrine(去氧腎上腺素)

α2-Ragonists:oxymetazoline(羥甲唑啉)apraclonidine(阿可樂定)β-Ragonists,

β1、β2-Ragonists:Isoprenaline

β1-Ragonists:dobutamine(多巴酚丁胺)

β2-Ragonists:

salbutamol(沙丁胺醇)section2α、β

-RagonistsAdrenaline(AD,腎上腺素)Ephedrine(麻黃堿)Dopamine(DA,多巴胺)Adrenaline(epinephrine,AD,腎上腺素)

SourceandChemistry1.adrenalmedulla:pheochromocyte(嗜鉻細胞)2.PNMT(苯乙胺-N-甲基轉(zhuǎn)移酶)

THDDCDβHPNMTTyr→→→dopa→→→→DA→→→→NA→→→→→AD

ADPharmacokinetics1.

Absorption2.Termination

Uptakemetabolism:MAO/COMT3.Excretion:VMA(3甲氧4羥扁桃酸)Normal:2-6.8mg/24hPheochromocytoma:10-250mg/24h(嗜鉻細胞瘤)pharmacologicalactions:

activateα,β-R1.heart:stronglyexcited(β1-R)positiveinotropiceffectpositivechronotropiceffectpositivedromotropiceffect

Coronary:dilation(1)Agonistβ2-R(2)Prolongdiastolicphase(3)Increasemyocardialoxygenconsumptionadenosine↑Advantageanddisadvantage2.vessels:

(1)contraction(α-R)

Skin,mucosa:strongKidney:strongjuxtaglomerularcells(β1-R):Reninrelease↑

Cerebral:

(2)dilation:

SkeletalMuscle(β2-R)

Coronary:directeffect:β2-Rindirecteffect:timeofperfusion

adenosine↑

pharmacologicalactions3.BP:

smalldose:SBP↑,DBP↓largedose:SBP↑,DBP↑

Doublephasedresponse

pharmacologicalactions4.smoothmuscle:

bronchialsmoothmuscle:

2,

1Gastrointestinaltract:(negativefeedback)

Uterus,bladder:

2Pupillarydilatormuscle:

1

pharmacologicalactions5.metabolism:↑20%-30%(1)Carbohydrate:bloodGlu↑

,

2:glycogenolysis↑(糖原分解)glyconeogenesis↑(糖原異生)

2:insulin↓

:glucagon↑(2)Lipolysis:bloodfattyacid↑

3:triglyceridelipase(三酰甘油酶)↑

6.skeletalmuscle7.CNSclinicaluses

1.cardiacarrest2.allergicshock:firstchoicecautions3.bronchialasthma4.prolongationoflocalanestheticduration5.topicalhemorrhage:0.1%6.glaucoma

adversereactionsArhythmiaHypertensionCNSreactionscontraindicationsEphedrine(麻黃堿)陳克恢(1898—1988)藥理學家。長期致力于中藥藥理研究,是20世紀國際藥理學的一代宗師,也是現(xiàn)代中藥藥理學研究的創(chuàng)始人。他的突出貢獻是,首先發(fā)現(xiàn)麻黃素的藥理作用,為推動交感胺類化合物的化學合成奠定了基礎(chǔ),并為從天然產(chǎn)物中尋找開發(fā)新藥起了典范作用。他還發(fā)現(xiàn)解救急性氰化合物中毒的方法,并被沿用至今。EphedrineMechanisms:1.directactions:

1,

1,

2

,

2-R2.indirectactions

Characteristics:1.stable,orally.2.action:slower,weakerandlongerVSAD3.centralexcitation4.tachyphylaxisActions:1.CNSeffects2.CVS3.Smoothmuscle4.Increaseskeletalmuscletension

ephedrineclinicaluses1.bronchialasthma2.nasalcongestion3.hypotensivestates4.Allergy(urticaria,angioneuroedema)adversereactionsCardiacandCNSexcitation

dopamine(DA,多巴胺)

Pharmacokinetics:

ivd,shortt1/2,notacrossBBB

pharmacologicalactionsactivateα,β1,DA

-R,↑NAreleasepharmacologicalactions

1.Cardiovascularsystem:

vessel:dilation(D1A-R),contraction(α-R)Smalldose:DBP↓(D1A-R)SBP→Midddledose:SBP↑(β1-R)DBP↑→Largedose:DBP↑(α-R)SBP↑2.renalvessels:smalldosedilation(D1A-R)largedosecontraction(α-R)clinicaluses

1.shock2.chronicheartfailure(CHF)3.acuterenalfailure(ARF)Mephentermine

(美芬丁胺,wyamine,恢壓敏)Similartoephedrine(direct,indirect)centralexcitationUsedtopreventhypotensionstateUsedtotreatnasalcongestionsection3α-Ragonistsα-Ragonists

α1、α2-Ragonistsα1-Ragonistsα2-Ragonists

1,

2Agonists

noradrenaline(去甲腎上腺素,norepinephrine,NA,NE)[sourceandchemistry]

NA

pharmacokineticspharmacologicalactionsstronglyactivateα1,α2-Rslightlyactivateβ1-R.pharmacologicalactions1.vessels:contraction(α-R)

coronaryvessels:dilation(similartoAD)presynapticadrenergicterminals(α2-R):NE↓negativefeedback2.heart:excitation(β1-R)3.BP:smalldose:SBP↑DBP→largedose:SBP↑DBP↑4.others:weakerthanADclinicaluses

1.shock:early2.hypotensioncausedbydrugs’intoxication3.upperdigestivetracthemorrhageadversereactions1.localischemiaandnecrosis2.acuterenalfailure

metaraminol

(間羥胺,aramine,阿拉明)[Mechanisms]1.directactions2.indirectactions[Characteristics]1.weakerandlongerthanNA2.littleadversereactions:renalfailure,arrhythmias3.tachyphylaxis[Uses]

substituteforNAintreatmentofshock

1-RAgonistsPhenylephrine(去氧腎上腺素)Methoxamine(甲氧明)Phenylephrineandmethoxamine

1.selectiveα1-Ragonists:shock,hypotension2.renalvasoconstriction:significant3.paroxysmalsupraventricular

tachycardia4.phenylephrine→mydriasis(rapid,weak,short)

2-RAgonistsPeripheral

2-RAgonists:

oxymetazoline(羥甲唑啉):nasalcongestionapraclonidine(阿可樂定):

GlaucomaCentral

2-RAgonists:HBP

clonidine(可樂定),methyldopa(甲基多巴)Section4β-Ragonistsβ1、β2-Ragonistβ1-Ragonistsβ2-Ragonistsβ1、β2-RagonistIsoprenaline(Isop,異丙腎上腺素)pharmacologicalactions:

stronglyactivateβ1、β2-Rpharmacologicalactions1.heart:excitation(β1-R)positiveinotropiceffectpositivechronotropiceffectpositivedrom

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論